A group of pregnant women standing together

Your Patient Asked About Connura.
Here’s What It Does and Doesn’t Do.

Built for pregnancy and postpartum
Works with the thresholds you give her
Patient-held PDF reports
Nothing new for your staff to install or monitor

Evidence-cited • ACOG default thresholds • Built for maternal health

Connura supports your clinical judgment.

Connura helps your patient carry out the plan you set, and gives her a report to bring her readings to you.

It fits the workflow you already have: she brings a PDF, much like a paper log.

Is Connura safe for my patient?

Connura is a tracking tool, not a medical device or a treatment. It records the readings she takes on her own upper-arm monitor and labels them against the thresholds you set.

In two large randomized trials of higher-risk pregnancies and of chronic or gestational hypertension, adding self-monitoring to usual care showed no clear difference in the maternal or perinatal outcomes measured. Rare events were too uncommon for firm safety conclusions, and no trial has tested Connura itself. See the research below.

Warning signs still come first. Some signs mean call your care team the same day, no matter the number: a reading at or above 160/110, a headache that won't go away, vision changes (blurry, spots or flashing lights), pain in the upper belly under the ribs, sudden swelling in the face or hands, or sudden nausea or trouble breathing.

What does Connura actually do?

What it does:

She logs the readings she takes on her own upper-arm monitor, with a step-by-step guide to measuring at home
She enters the high and severe thresholds you give her. Until she does, Connura uses ACOG's definitions as defaults: 140/90 and 160/110. The severe threshold can be lowered but not set above 160/110
Each reading gets a status label against her thresholds. The app also has built-in "low" and "elevated" labels that you can't change. These use Connura's fixed cutoffs, not your thresholds
For an elevated, high or severe reading, Connura opens a short guide that points her back to the plan you discussed and offers a recheck. For a severe reading, it also offers one tap to call your office and tells her to contact emergency services if she feels unsafe
Trends over time, labelled by week of pregnancy, continuing after delivery
A PDF report she shares with you at appointments or through your patient portal
Reminders she can set to keep measuring

What it doesn't do:

Make clinical decisions or treatment recommendations
Store your action plan — only her thresholds and your clinic's phone number
Send alerts or data to your practice — her readings stay on her phone until she shares them
Integrate with your EMR
Replace prenatal appointments or your clinical judgment

What's my role?

You remain the clinical decision-maker:

Set her high and severe thresholds and tell her what to do when a reading is above them
Check her technique, and that her monitor is validated for pregnancy and the cuff fits her arm
Review the trend she shares at appointments
Make all treatment decisions based on your clinical assessment

Connura supports your judgment. It doesn't replace it.

Get the Patient Guide

The Gap Between Office Visits

A pregnant woman sitting at home on a sofa with her hand on her forehead, looking tired and showing potential symptoms of high blood pressure.

Between appointments, your patient may worry about missing early warning signs, forget details of your technique instructions, and fear postpartum complications if monitoring stops.

What the research shows:

Office visits capture snapshots, not patterns

A clinic reading is a single point in time. In a descriptive analysis of 1,054 BUMP 1 participants who self-monitored, 22.8% had raised home readings but normal clinic readings, and 4.1% the reverse. The trial did not test how those patterns should change care.

Engagement fades over time

In one single-arm postpartum program, more than 90% of patients sent readings in week 1, falling to about half by the final week.

Postpartum is when follow-up slips

In two randomized trials, only 44–58% of patients with office-only follow-up had a BP recorded in the first 10 days after discharge
With text- or app-based remote monitoring, about 92% did

Your patient isn’t overreacting

The Gap is Real

Line drawing of a pregnant woman holding a heart-shaped object connected to a string, with her head bowed and eyes closed.

What to Tell Your Patient About Home Monitoring

Technique Essentials

Sit quietly for 5 minutes before measuring
Back supported, feet flat on floor, arm at heart level
Avoid caffeine and exercise 30 minutes prior
Same time each day, same arm, cuff positioned correctly
Take 2 readings 1 minute apart, record both

Agree Her Plan

Her thresholds: the readings you want her to act on. She enters them in Connura
What to do when a reading is above them, and how soon
Who to call after hours and on weekends
Some signs mean calling you the same day, no matter the number: a reading at or above 160/110, a headache that won't go away, vision changes, upper-belly pain, sudden swelling, sudden nausea or trouble breathing

What Connura Provides

Status labels against the thresholds you set
Trends over time, from pregnancy into postpartum
A step-by-step guide to measuring at home
PDF reports she can share with you

What Connura Doesn't Provide

Medical advice or clinical decisions (that's your role)
Alerts or data sent to your practice
Emergency response
Replacement for scheduled prenatal visits
Medication management or dosing recommendations

How Connura Works

Step 1: You Set Her Plan

During the office visit, you:

Assess her risk profile (chronic hypertension, previous preeclampsia, first pregnancy)
Set her high and severe thresholds, and revisit them as her pregnancy progresses
Tell her what to do if a reading is above them: when to recheck, when to call your clinic, when to go to labor and delivery
Teach measurement technique

Step 2: You Check Her Monitor

Before she starts home monitoring:

Have her bring her BP monitor to the office
Confirm the monitor model is validated for pregnancy and the cuff fits her arm
Watch her take a reading to check her technique
You can compare a home and a clinic reading, but differences are inconsistent, so don't use a one-time comparison to correct her readings

Step 3: She Enters Your Thresholds in Connura

She enters the high and severe thresholds you gave her (until she does, Connura uses ACOG's 140/90 and 160/110)
She saves your clinic's phone number
You agree when she'll share readings with you (every appointment, weekly, or as needed)

Your action plan itself isn't stored in the app, so make sure she has it in writing.

Step 4: She Measures at Home

Connura gives her:

A step-by-step guide to measuring (rest, positioning, timing)
A simple log for each reading
Reminders she can set to keep measuring on the schedule you agreed

Step 5: Each Reading Gets a Status Label

After each reading, she sees:

Its status against her thresholds (plus built-in "low" and "elevated" labels that use Connura's fixed cutoffs, not your thresholds)
Her recent readings in her log and trends
For an elevated, high or severe reading, a short guide that points her back to your plan and offers a recheck
For a severe reading, one tap to call your office

Step 6: She Shares a Report With You

She generates a PDF for the period she chooses, showing:

Daily reading counts and morning and evening averages
Daily ranges and a trend chart
A summary of readings by status
Her thresholds
Week of pregnancy, or postpartum status

She brings it to appointments or sends it through your patient portal.

No EMR integration required

Nothing new for your staff to install or monitor

Clinician FAQ

Built on Pregnancy-Specific Research

No trial has tested Connura itself. The studies below are of structured home BP monitoring programs in pregnancy and after delivery.

What is known about the safety of home BP monitoring in pregnancy?

Tucker 2022, BUMP 1

(RCT, n=2,441, higher-risk pregnancies): no statistically significant difference in severe hypertension, preeclampsia, small-for-gestational-age birth or NICU admission; serious adverse events were rare (1% vs 0.5%) and none were judged related to monitoring; the trial was not powered to detect rare serious events [1].

Chappell 2022, BUMP 2

(RCT, n=850, chronic or gestational hypertension): no serious adverse events judged related to monitoring; not powered to detect rare serious events [2].

Yeh 2022

(systematic review): no clear difference for most outcomes (low-to-moderate certainty); one trial found more caesarean births in chronic hypertension [3].

Does it change outcomes?

Tucker 2022, BUMP 1:

time to clinic-recorded hypertension −1.6 days (95% CI −8.1 to +4.9), no difference [1].

Chappell 2022, BUMP 2:

no difference in clinic BP control [2].

Kitt 2023, POP-HT

(RCT, n=220, postpartum, clinician-guided medication changes): lower diastolic BP at 9 months (−5.8 mmHg on 24-hour monitoring); BP-related readmissions 7% vs 27%, but this can't be attributed to self-monitoring alone [4].

Hirshberg 2018

(RCT, n=206): hypertension readmissions 0 of 103 with remote monitoring vs 4 of 103 with office follow-up; small trial, too few events for a reliable comparison [5].

Arkerson 2023

(RCT, n=197): readmissions 5.0% vs 4.2% (remote vs office), no difference [6].

Are home readings accurate?

Topouchian 2018

(validation study, including women with preeclampsia): Omron M3 Comfort and Evolv met the validation standard in pregnancy [7].

Tran 2021

(systematic review and meta-analysis, 19 studies; 15 in the pooled comparison): home readings averaged about 4/3 mmHg lower than office readings, with high variation between studies [8].

Bowen 2021, OPTIMUM-BP

(secondary analysis, n=91): readings on a median 77–85% of days [9].

Lawrence 2023

(n=176, urban Ghana): 12.1% performed every measurement step correctly before training and 96.6% immediately after; long-term retention wasn't tested [10].

What about after delivery?

Hirshberg 2018

(RCT, n=206): BP recorded in the first 10 days, 92.2% vs 43.7% [5].

Arkerson 2023

(RCT, n=197): 91.7% vs 58.4%; with remote monitoring 92.9% of Black and White patients alike, vs 41.2% (Black) and 69.5% (White) with office visits, in small subgroups [6].

Steele 2023

(systematic review): about twice as likely to have BP recorded, RR 2.11 (1.68–2.65) [11].

Mujic 2024

(single-arm program, n=1,033): engagement fell from more than 90% in week 1 to about half by the final week [12].

Will patients use it, and what do clinicians think?

Thomas 2021

(survey, n=128): 84% very or extremely satisfied, 91% would recommend; 85% reported at least one problem with the BP cuff [13].

Rajkumar 2025

(survey, 65 clinicians): 72.3% agreed remote BP monitoring could help care decisions; 24.6% raised safety concerns [14].

Atluri 2023

(survey, 75 doctors, Ghana): 90.7% would recommend home BP monitoring [15].

References

Tucker KL, et al. Effect of Self-monitoring of Blood Pressure on Diagnosis of Hypertension During Higher-Risk Pregnancy: The BUMP 1 Randomized Clinical Trial. JAMA. 2022. PMID 35503346. doi:10.1001/jama.2022.4712
Chappell LC, et al. Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals With Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical Trial. JAMA. 2022. PMID 35503345. doi:10.1001/jama.2022.4726
Yeh PT, et al. Self-monitoring of blood pressure among women with hypertensive disorders of pregnancy: a systematic review. BMC Pregnancy Childbirth. 2022. PMID 35641913. doi:10.1186/s12884-022-04751-7
Kitt J, et al. Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial. JAMA. 2023. PMID 37950919. doi:10.1001/jama.2023.21523
Hirshberg A, et al. Comparing standard office-based follow-up with text-based remote monitoring in the management of postpartum hypertension: a randomised clinical trial. BMJ Qual Saf. 2018. PMID 29703800. doi:10.1136/bmjqs-2018-007837
Arkerson BJ, et al. Remote Monitoring Compared With In-Office Surveillance of Blood Pressure in Patients With Pregnancy-Related Hypertension: A Randomized Controlled Trial. Obstet Gynecol. 2023. PMID 37734091. doi:10.1097/AOG.0000000000005327
Topouchian J, et al. Clinical accuracy of the Omron M3 Comfort® and the Omron Evolv® for self-blood pressure measurements in pregnancy and pre-eclampsia - validation according to the Universal Standard Protocol. Vasc Health Risk Manag. 2018. PMID 30214220. doi:10.2147/VHRM.S165524
Tran K, et al. Home blood pressure monitoring in the diagnosis and treatment of hypertension in pregnancy: a systematic review and meta-analysis. CMAJ Open. 2021. PMID 34131027. doi:10.9778/cmajo.20200099
Bowen L, et al. Adherence with blood pressure self-monitoring in women with pregnancy hypertension, and comparisons to clinic readings: A secondary analysis of OPTIMUM-BP. Pregnancy Hypertens. 2021. PMID 34082300. doi:10.1016/j.preghy.2021.05.016
Lawrence ER, et al. Ability and accuracy of patient-performed blood pressure monitoring among pregnant women in urban Ghana. AJOG Glob Rep. 2023. PMID 37645652. doi:10.1016/j.xagr.2023.100243
Steele DW, et al. Postpartum Home Blood Pressure Monitoring: A Systematic Review. Obstet Gynecol. 2023. PMID 37311173. doi:10.1097/AOG.0000000000005270
Mujic E, et al. Implementation of a Cell-Enabled Remote Blood Pressure Monitoring Program During the Postpartum Period at a Safety-Net Hospital. J Am Heart Assoc. 2024. PMID 38934890. doi:10.1161/JAHA.123.034031
Thomas NA, et al. Patient perceptions, opinions and satisfaction of telehealth with remote blood pressure monitoring postpartum. BMC Pregnancy Childbirth. 2021. PMID 33607957. doi:10.1186/s12884-021-03632-9
Rajkumar T, et al. Clinician and patient perceptions around implementing remote blood pressure monitoring for hypertensive disorders of pregnancy: A survey-based study. Digit Health. 2025. PMID 40718404. doi:10.1177/20552076251317567
Atluri N, et al. Benefits and barriers of home blood pressure monitoring in pregnancy: perspectives of obstetric doctors from a Ghanaian tertiary hospital. BMC Pregnancy Childbirth. 2023. PMID 36658509. doi:10.1186/s12884-023-05363-5
American College of Obstetricians and Gynecologists. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020. PMID 32443079. doi:10.1097/AOG.0000000000003891

Guideline: ACOG Practice Bulletin No. 222 [16] defines hypertension in pregnancy; Connura's default thresholds follow it.

Your Patient Asked About Connura.Here’s What It Does and Doesn’t Do.